EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study

Rikiya Taoka, Masaki Kamada, Kazuyoshi Izumi, Ryuta Tanimoto, Kei Daizumoto, Yushi Hayashida, Katsutoshi Uematsu, Hironobu Arai, Takeshi Sano, Ryoichi Saito, Hiromi Hirama, Toshihiro Kobayashi und 10 weitere

International Journal of Clinical Oncology · 2024

DOI: 10.1007/s10147-024-02481-8 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Clinical Oncology, 2024. Verfasst von Rikiya Taoka und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kita-gun, Kagawa, Japan. taoka.rikiya@kagawa-u.ac.jp. Hauptthemen laut MEDLINE: Peripheral Nervous System Diseases, Antibodies, Monoclonal. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Nervous System DiseasesAntibodies, MonoclonalHumansMaleFemaleAgedProspective StudiesMiddle AgedAged, 80 and overNeural ConductionUrinary Bladder NeoplasmsCarcinoma, Transitional CellProgression-Free SurvivalUrologic Neoplasms

Stichwörter der Autor:innen

Enfortumab vedotinNerve conduction studyPeripheral neuropathyUrothelial carcinoma

Substanzen

enfortumab vedotinAntibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Urology, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kita-gun, Kagawa, Japan. taoka.rikiya@kagawa-u.ac.jp.
  • Department of Neurological Intractable Disease Research, Kagawa University School of Medicine, Kita, Japan.
  • Department of Urology, Takamatsu Red Cross Hospital, Takamatsu, Japan.
  • Department of Urology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
  • Department of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Department of Urology, Sakaide City Hospital, Sakaide, Japan.

Zitieren

APA

Taoka, R., Kamada, M., Izumi, K., Tanimoto, R., Daizumoto, K., Hayashida, Y., Uematsu, K., Arai, H., Sano, T., Saito, R., Hirama, H., Kobayashi, T., Honda, T., Osaki, Y., Abe, Y., Naito, H., Tohi, Y., Matsuoka, Y., Kato, T., …, & Sugimoto, M. (2024). Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-024-02481-8

Vancouver

Taoka R, Kamada M, Izumi K, Tanimoto R, Daizumoto K, Hayashida Y, et al. Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study. International Journal of Clinical Oncology. 2024. doi:10.1007/s10147-024-02481-8

BibTeX
@article{Taoka2024,
  author = {Taoka, Rikiya and Kamada, Masaki and Izumi, Kazuyoshi and Tanimoto, Ryuta and Daizumoto, Kei and Hayashida, Yushi and Uematsu, Katsutoshi and Arai, Hironobu and Sano, Takeshi and Saito, Ryoichi and Hirama, Hiromi and Kobayashi, Toshihiro and Honda, Tomoko and Osaki, Yu and Abe, Yohei and Naito, Hirohito and Tohi, Yoichiro and Matsuoka, Yuki and Kato, Takuma and Okazoe, Homare and Ueda, Nobufumi and Sugimoto, Mikio},
  title = {Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study},
  journal = {International Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1007/s10147-024-02481-8}
}
Kostenlos starten →